Manuel Comabella

Barcelona, CT, Spain

Last Updated: 09/26/2026

Save publications for later

Sign Up

Not sure about your diagnosis?

Check Your Symptoms

Found 254 publications

Refining Treatment Monitoring in Patients With Relapsing Multiple Sclerosis Based on Changes on Neurofilament Light Chain Z-Scores.

Refining Treatment Monitoring in Patients With Relapsing Multiple Sclerosis Based on Changes on Neurofilament Light Chain Z-Scores.

Journal: Neurology

Published: August 20, 2026

Unscheduled DNA synthesis reveals a DNA repair hotspot and biomarker of somatic instability at the expanded-CAG repeat tract in the huntingtin gene.

Unscheduled DNA synthesis reveals a DNA repair hotspot and biomarker of somatic instability at the expanded-CAG repeat tract in the huntingtin gene.

Journal: bioRxiv : the preprint server for biology

Published: August 20, 2026

Live Attenuated Measles-Mumps-Rubella and Varicella Vaccinations and Multiple Sclerosis Activity.

Live Attenuated Measles-Mumps-Rubella and Varicella Vaccinations and Multiple Sclerosis Activity.

Journal: JAMA network open

Published: May 20, 2026

Chronological ageing and ovarian reserve in MS: insights from anti-Müllerian hormone and disability progression.

Chronological ageing and ovarian reserve in MS: insights from anti-Müllerian hormone and disability progression.

Journal: Journal of neurology, neurosurgery, and psychiatry

Published: March 03, 2026

Chronological ageing and ovarian reserve in MS: insights from anti-Müllerian hormone and disability progression.

Chronological ageing and ovarian reserve in MS: insights from anti-Müllerian hormone and disability progression.

Journal: Journal of neurology, neurosurgery, and psychiatry

Published: March 03, 2026

"Low-Positive" MOG-IgG Cases Among Adults With a First Event Suggestive of Multiple Sclerosis.

"Low-Positive" MOG-IgG Cases Among Adults With a First Event Suggestive of Multiple Sclerosis.

Journal: Annals of clinical and translational neurology

Published: February 20, 2026

A glial oxidative signature predicts disability in primary progressive multiple sclerosis and is associated with long-term cognitive decline.

A glial oxidative signature predicts disability in primary progressive multiple sclerosis and is associated with long-term cognitive decline.

Journal: Frontiers in immunology

Published: February 02, 2026

Optic nerve imaging with OCT predicts disease progression and monitors brain and spinal atrophy in primary progressive multiple sclerosis.

Optic nerve imaging with OCT predicts disease progression and monitors brain and spinal atrophy in primary progressive multiple sclerosis.

Journal: Multiple sclerosis (Houndmills, Basingstoke, England)

Published: January 30, 2026

Proinflammatory Epstein-Barr Virus Antibody Functions Track with Disease Activity in Multiple Sclerosis.

Proinflammatory Epstein-Barr Virus Antibody Functions Track with Disease Activity in Multiple Sclerosis.

Journal: Annals of neurology

Published: January 13, 2026

Biomarker discovery using NUcleic Acid-Linked Immuno-Sandwich Assay in multiple sclerosis patients experiencing progression independent of relapse activity.

Biomarker discovery using NUcleic Acid-Linked Immuno-Sandwich Assay in multiple sclerosis patients experiencing progression independent of relapse activity.

Journal: Multiple sclerosis (Houndmills, Basingstoke, England)

Published: November 05, 2025

New serum soluble factors predicting inflammatory and non-inflammatory disability worsening in multiple sclerosis.

New serum soluble factors predicting inflammatory and non-inflammatory disability worsening in multiple sclerosis.

Journal: Frontiers in immunology

Published: October 21, 2025

Impact of preanalytical factors on blood CHI3L1 levels.

Impact of preanalytical factors on blood CHI3L1 levels.

Journal: Frontiers in immunology

Published: October 08, 2025

Showing 1-12 of 254

Last Updated: 09/26/2026